Pharmaceuticals: Major
Swiss companies operating in the same pharmaceuticals: major industry
The table below has Swiss companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Novartis AG. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 891.51 B CHF | 946.057 CHF | −0.67% | 2 | 0.25 | 39.77 | 23.79 CHF | +98.82% | 0.58% | Health technology | Buy |
| LLYEli Lilly and Company | 891.51 B CHF | 955 CHF | 0.00% | 1 | 0.18 | 40.14 | 23.79 CHF | +98.82% | 0.58% | Health technology | Buy |
 JNJJohnson & Johnson | 534.46 B CHF | 221.735 CHF | +0.51% | 16 | 2.96 | 31.79 | 6.97 CHF | −5.99% | 1.96% | Health technology | Buy |
 MRK.USDMerck & Co., Inc. | 297.65 B CHF | 137.78 USD | 0.00% | 8.29 K | 8.24 | 110.13 | 1.01 CHF | −80.71% | 2.29% | Health technology | Buy |
| 6MKMerck & Co., Inc. | 297.65 B CHF | 121.437 CHF | +1.07% | 3 | 0.07 | 120.08 | 1.01 CHF | −80.35% | 2.29% | Health technology | Buy |
 ROPRoche Holding Ltd | 284.73 B CHF | 362.921 CHF | +1.66% | 408 | 0.84 | 23.68 | 15.33 CHF | +30.49% | 2.75% | Health technology | Buy |
| RORoche Holding Ltd | 284.73 B CHF | 373.2 CHF | +2.30% | 29.62 K | 0.91 | 24.35 | 15.33 CHF | +30.49% | 2.96% | Health technology | Buy |
| ROPRoche Holding Ltd | 284.73 B CHF | 364.8 CHF | +2.24% | 648.97 K | 0.58 | 23.80 | 15.33 CHF | +30.49% | 2.75% | Health technology | Buy |
| RHORoche Holding Ltd | 284.73 B CHF | 366.857 CHF | +0.35% | 35 | 1.29 | 23.94 | 15.33 CHF | +30.49% | 2.96% | Health technology | Buy |
 ZEGAstraZeneca PLC | 212.81 B CHF | 139.011 CHF | +0.74% | 6 | 0.18 | 26.03 | 5.34 CHF | +19.20% | 0.00% | Health technology | Strong buy |
 NOVNNovartis AG | 210.7 B CHF | 116.14 CHF | +0.90% | 2.02 M | 0.44 | 22.09 | 5.26 CHF | −11.50% | 3.21% | Health technology | Buy |
| NOVNEENovartis AG TEMP | 210.7 B CHF | 116.90 CHF | +1.11% | 400 K | 1.25 | 22.24 | 5.26 CHF | −11.50% | 3.21% | Health technology | No rating |
| NOTNovartis AG | 210.7 B CHF | 116.415 CHF | +0.53% | 760 | 0.38 | 22.14 | 5.26 CHF | −11.50% | 3.21% | Health technology | Buy |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 157.16 B CHF | 35.657 CHF | +1.90% | 3.3 K | 8.69 | 10.78 | 3.31 CHF | +14.88% | 2.85% | Health technology | Neutral |
| NOVNovo Nordisk A/S Class B | 156.85 B CHF | 32.786 CHF | −8.83% | 2.81 K | 6.91 | 10.16 | 3.23 CHF | +3.62% | 4.16% | Health technology | Neutral |
 PFE.USDPfizer Inc. | 129.5 B CHF | 27.515 USD | −1.40% | 17 | — | 36.43 | 0.61 CHF | −59.83% | 6.22% | Health technology | Neutral |
| PFEPfizer Inc. | 129.5 B CHF | 22.767 CHF | +0.66% | 439 | 4.95 | 37.29 | 0.61 CHF | −59.07% | 6.22% | Health technology | Neutral |
 SNWSanofi SA | 83.66 B CHF | 70.622 CHF | +1.47% | 150 | 0.47 | 22.98 | 3.07 CHF | −36.38% | 5.56% | Health technology | Buy |
| SANSanofi SA | 83.66 B CHF | 71.80 CHF | 0.00% | 800 | 0.01 | 23.36 | 3.07 CHF | −36.38% | 5.56% | Health technology | Buy |
 GS71GSK plc | 82.59 B CHF | 20.871 CHF | +1.81% | 2 | 0.00 | 16.51 | 1.26 CHF | +39.95% | 3.62% | Health technology | Neutral |
 BAYNBayer AG | 44.5 B CHF | 46.34 CHF | 0.00% | 600 | 1.27 | — | −1.63 CHF | +49.77% | 0.23% | Health technology | Buy |
| BAYNBayer AG | 44.5 B CHF | 46.185 CHF | +0.42% | 28 | 0.27 | — | −1.63 CHF | +49.77% | 0.23% | Health technology | Buy |
 UNCUCB S.A. | 37.24 B CHF | 190.947 CHF | −4.20% | 30 | 0.85 | 18.29 | 10.44 CHF | +62.96% | 0.49% | Health technology | Strong buy |
 GALDGalderma Group AG | 36.88 B CHF | 161.25 CHF | +1.96% | 635.99 K | 0.52 | 55.53 | 2.90 CHF | +110.71% | 0.22% | Health technology | Strong buy |
| GALDGalderma Group AG | 36.88 B CHF | 161.991 CHF | +1.67% | 631 | 2.59 | 55.78 | 2.90 CHF | +110.71% | 0.22% | Health technology | Strong buy |
 D8YSandoz Group Ltd | 30.19 B CHF | 69.827 CHF | +2.43% | 1.54 K | 1.32 | 59.31 | 1.18 CHF | +166.48% | 1.17% | Health technology | Buy |
| SDZSandoz Group Ltd | 30.19 B CHF | 69.72 CHF | +1.60% | 1.27 M | 0.47 | 59.22 | 1.18 CHF | +166.48% | 1.17% | Health technology | Buy |
 ZOEZoetis, Inc. Class A | 24.24 B CHF | 57.999 CHF | −3.92% | 10 | 0.15 | 11.80 | 4.91 CHF | +6.56% | 2.93% | Health technology | Buy |
 VTRSViatris, Inc. | 15.99 B CHF | 13.450 CHF | +2.44% | 37 | 0.55 | — | −0.29 CHF | +87.49% | 2.83% | Health technology | Buy |
 BANBBachem Holding AG Class B | 5.89 B CHF | 80.80 CHF | +2.86% | 139.43 K | 1.45 | 40.65 | 1.99 CHF | +11.05% | 1.15% | Health technology | Buy |
| BANBBachem Holding AG Class B | 5.89 B CHF | 80.130 CHF | +2.54% | 453 | 6.11 | 40.32 | 1.99 CHF | +11.05% | 1.15% | Health technology | Buy |
 SFZNSiegfried Holding AG | 3.3 B CHF | 72.60 CHF | −0.75% | 101.87 K | 0.92 | 18.57 | 3.91 CHF | +11.09% | 0.55% | Health technology | Buy |
| SFZNSiegfried Holding AG | 3.3 B CHF | 73.051 CHF | −1.79% | 60 | 0.32 | 18.68 | 3.91 CHF | +11.09% | 0.55% | Health technology | Buy |
 IDIAIdorsia Ltd. | 1.3 B CHF | 4.796 CHF | −0.83% | 697.36 K | 0.53 | — | −1.31 CHF | −63.44% | 0.00% | Health technology | Buy |
| 19TIdorsia Ltd. | 1.3 B CHF | 4.818 CHF | −3.47% | 2.03 K | 1.91 | — | −1.31 CHF | −63.44% | 0.00% | Health technology | Buy |
 UP0Ultragenyx Pharmaceutical, Inc. | 1.18 B CHF | 10.764 CHF | −16.55% | 150 | 1.73 | — | −4.72 CHF | −7.65% | 0.00% | Health technology | Buy |
 CMHCCosmo N.V. | 921.02 M CHF | 56.6 CHF | +3.47% | 25.37 K | 0.75 | — | −0.35 CHF | −111.27% | 3.53% | Health technology | Strong buy |
 PK5Basilea Pharmaceutica AG | 848.87 M CHF | 70.009 CHF | +0.63% | 10 | 0.16 | 17.94 | 3.90 CHF | −27.09% | 0.00% | Health technology | Buy |
| BSLNBasilea Pharmaceutica AG | 848.87 M CHF | 69.0 CHF | 0.00% | 35.9 K | 0.79 | 17.68 | 3.90 CHF | −27.09% | 0.00% | Health technology | Buy |
 S3F0Santhera Pharmaceuticals Holding AG | 243.48 M CHF | 15.776 CHF | +1.59% | 1.78 K | 3.88 | — | −3.82 CHF | −11.07% | 0.00% | Health technology | Strong buy |
| SANNSanthera Pharmaceuticals Holding AG | 243.48 M CHF | 16.10 CHF | +1.00% | 40.62 K | 0.62 | — | −3.82 CHF | −11.07% | 0.00% | Health technology | Strong buy |
 NWRNNewron Pharmaceuticals S.p.A. | 236.6 M CHF | 11.24 CHF | +0.90% | 43.2 K | 0.88 | — | −0.62 CHF | −187.61% | 0.00% | Health technology | Strong buy |
 CURNCuratis Holding AG | 107.29 M CHF | 18.50 CHF | −8.42% | 6.36 K | 2.83 | — | −0.13 CHF | +61.88% | 0.00% | Health technology | No rating |
 APEAddex Therapeutics Ltd | 2.62 M CHF | 0.024 CHF | −29.41% | 20 K | 1.36 | — | −0.06 CHF | −283.78% | 0.00% | Health technology | No rating |
| ADXNAddex Therapeutics Ltd | 2.62 M CHF | 0.0222 CHF | 0.00% | 149.31 K | 0.21 | — | −0.06 CHF | −283.78% | 0.00% | Health technology | No rating |